title: Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.
authors: Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini stefano.sacchi@unimore.it.
authors: Stefano
authors: S
authors: Sacchi
authors: Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini.
authors: Raffaella
authors: R
authors: Marcheselli
authors: Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini.
authors: Alessia
authors: A
authors: Bari
authors: Division of Hematology, University of Pisa, Rimini.
authors: Gabriele
authors: G
authors: Buda
authors: Hematology Unit, Infermi Hospital, Rimini.
authors: Anna Lia
authors: AL
authors: Molinari
authors: Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Piacenza.
authors: Luca
authors: L
authors: Baldini
authors: Hematology Unit, Guglielmo da Saliceto Hospital, Piacenza.
authors: Daniele
authors: D
authors: Vallisa
authors: Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini.
authors: Marina
authors: M
authors: Cesaretti
authors: Hematology and SCT Unit, IRCCS-CROB, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Meldola.
authors: Pellegrino
authors: P
authors: Musto
authors: Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola.
authors: Sonia
authors: S
authors: Ronconi
authors: Unit of Hematology with Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Reggio Emilia.
authors: Giorgina
authors: G
authors: Specchia
authors: Department of Biomedical Sciences and Human Oncology, University of Bari "A. Moro", Reggio Emilia.
authors: Franco
authors: F
authors: Silvestris
authors: Division of Internal Medicine, Cesena Hospital, Hematology Unit, Azienda Ospedaliera Arcispedale Santa Maria Nuova, IRCCS, Reggio Emilia.
authors: Luciano
authors: L
authors: Guardigni
authors: Angela
authors: A
authors: Ferrari
authors: Department of Hematology, Città della Salute e della Scienza Hospital and University of Torino, Genova.
authors: Annalisa
authors: A
authors: Chiapella
authors: Hematology Unit, San Martino Hospital, Genova.
authors: Angelo Michele
authors: AM
authors: Carella
authors: Department of Hematology & Oncology, Humanitas Cancer Center, Humanitas Clinical & Research, Rozzano.
authors: Armando
authors: A
authors: Santoro
authors: Division of Haematology, AOU "Policlinico-Vittorio Emanuele", University of Catania, Italy.
authors: Francesco
authors: F
authors: Di Raimondo
authors: Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini.
authors: Luigi
authors: L
authors: Marcheselli
authors: Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini.
authors: Samantha
authors: S
authors: Pozzi
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007558:Italy / Q000453:epidemiology; D000077269:Lenalidomide; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab / Q000008:administration & dosage / Q000009:adverse effects; D015996:Survival Rate; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D000069283:Rituximab; D013792:Thalidomide; D000077269:Lenalidomide
keywords: efficacy; indolent; lenalidomide; non-follicular lymphoma; recurrent; rituximab; safety